TGViewer
Graph Machine Learning Graph Machine Learning @graphml · 6.59K subscribers
Post #636 3.37K
Successful Phase I Cancer Vaccine Trials Powered by Graph ML

Transgene and NEC Corporation published a press release on the successful Phase I trials of TG4050, neoantigen cancer vaccine, tested on ovarian cancer, head and neck cancer. The release outlines the NEC's Neoantigen Prediction System based on Graph ML algorithms.

We reached out to Mathias Niepert, Chief Research Scientist of NEC Labs, to shed a bit more light on the graph ml setup and he kindly provided a few interesting details! Mathias says:

The main graph ML method is derived from Embedding Propagation which is a GNN that’s trained in an unsupervised way and, crucially, is able to handle / impute missing data in embedding space. The most relevant papers are Learning Graph Representations with Embedding Propagation (NeurIPS 2017) and Learning Representations of Missing Data for Predicting Patient Outcomes

A major challenge is that for each neoantigen we have some measurements but not all. Obtaining some of these requires expensive tests and some have to be collected from previous biomedical studies. One ends up with several very different feature types (requiring different ML encoders) and, for each such feature type, we only sometimes have a value. The graph-based ML method helps to impute and learn a unifying embedding space.

The graph itself is created based on specific similarity measures between proteins and is not given a-priori. Having a general graph, the task is to rank peptide candidates which would be most efficient for a given patient.

From a probe of a patient's cancer and healthy cells, you get several tens of thousands of neoantigen candidates. To manufacture a personalized vaccine, you have to narrow this down to several dozen candidates. These candidates should have two properties (1) likelihood to elicit immune response (2) different from healthy cell antigen. You end up scoring the neoantigens with the ML method, take the top K, and based on these you synthesize the vaccine. Graph ML is one component of a pretty complex system.

Mathias would like to emphasize that this is based on the work of several people at NEC and most credit should go to the domain experts who have collected the data and adapted and applied the graph ML methods to this problem.
NEC Transgene and NEC announce positive preliminary data from Phase I studies of TG4050, a novel individualized neoantigen cancer vaccine Positive initial data generated in the first six patients treated with TG4050 demonstrate the strong potential of this individualized immunotherapy in ovarian cancer and head and neck cancer
More from @graphml
  1. Mar 18, 2026🚀 LOGML 2026 — Mentor Applications Open (Deadline extended!) The LOGML (London Geometry a…
  2. Feb 28, 2026PhD Position in Graph Learning at the University of Vienna, Austria A PhD student position…
  3. Feb 16, 2026Uni Leipzig looking for a motivated student for a PhD position in Graph Machine Learning a…
  4. Oct 2, 2025Tired of evaluating your graph ML models on Cora, CiteSeer, and PubMed? We have a better b…
  5. Oct 2, 2025How can we create general-purpose graph foundation models? (by Dmitry Eremeev) For a long…
  6. Sep 21, 2025GraphML News (September 2025) - Stanford Graph Learning WS, MoML, RF Diffusion 3 While the…
Threads Profile ViewerView any public Threads profile without an account.Open ThreadLook →Writing with AI? Make it sound human.Metric37 rewrites AI drafts so they read naturally. Free AI detector, 1,500 words free.Try Metric37 →